|
2/2024
vol. 10
Original paper
Prevalence of HDV infections in Poland based on the experience of a single center in Silesia and literature research
Ewa Pałczyńska-Gwiazdowicz
1
,
Barbara Sobala-Szczygieł
1
,
- Department of Infectious Diseases and Hepatology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
- ID Clinic, Hepatology Outpatient Department, Mysłowice, Poland
- Department of Basic Medical Sciences, Faculty of Health Sciences, Medical University of Silesia, Bytom, Poland
Clin Exp HEPATOL 2024; 10, 2: 137-143
Online publish date: 2024/06/18
Get citation
PlumX metrics:
1. Netter HJ, Barrios MH, Littlejohn M, Yuen LKW. Hepatitis delta virus (HDV) and delta-like agents: Insights into their origin. Front Microbiol 2021; 12: 652962. 2.
Sagnelli C, Sagnelli E, Russo A, et al. HBV/HDV co-infection: Epidemiological and clinical changes, recent knowledge and future challenges. Life (Basel) 2021; 11: 169. 3.
Taylor JM. Hepatitis delta virus. Virology 2006; 344: 71-76. 4.
Stockdale AJ, Kreuels B, Henrion MYR, et al. The global prevalence of hepatitis D virus infection: Systematic review and metaanalysis. J Hepatol 2020; 73: 523-532. 5.
Hayashi T, Takeshita Y, Hutin YJF, et al. The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response? Arch Public Health 2021; 79: 180. 6.
Bielawski KP, Zietkowski D, Charmuszko U, et al. Hepatitis delta virus infection in chronically HBV-infected patients from northern Poland. Arch Virol 2006; 151: 1207-1215. 7.
Pleśniak R, Wawrzynowicz-Syczewska M. Prevalence of hepatitis delta infections among HBs-antigen-positive inhabitants of southeastern and northwestern parts of Poland. Clin Exp Hepatol 2019; 5: 232-236. 8.
Tseligka ED, Clément S, Negro F. HDV pathogenesis: Unravelling Ariadne’s thread. Viruses 2021; 13: 778. 9.
D’Souza S, Lau KC, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26: 5759-5783. 10.
DIM.CE.pdf [Internet] (cited 2023 Aug 3). Available from: http://npt.ir/uploads/DIM.CE.pdf 11.
HDV_Ab_competitive.pdf [Internet] (cited 2023 Aug 3). Available from: http://www.harmony-vos.sk/MIKROBIOLOGIA/INSERT/HDV_Ab_competitive.pdf 12.
DAG.CE-Insert-Rev.1-0911-Eng.pdf [Internet] (cited 2023 Aug 3). Available from: http://weldonbiotech.com/wp-content/uploads/2018/04/DAG.CE-Insert-Rev.1-0911-Eng.pdf 13.
Laskus T. Infection with hepatitis delta virus among drug addicts. Pol Tyg Lek 1992; 47: 247-250. 14.
Chlabicz S, Grzeszczuk A, Lapiński TW, et al. Search for hepatitis delta virus (HDV) infection in hepatitis C patients in north-eastern Poland. Comparison with anti-HDV prevalence in chronic hepatitis B. Eur J Epidemiol 2003; 18: 559-561. 15.
Da BL, Rahman F, Lai WC, et al. Risk factors for delta hepatitis in a North American cohort: Who should be screened? Am J Gastroenterol 2021; 116: 206-209. 16.
Pascarella S, Negro F. Hepatitis D virus: an update. Liver Int 2011; 31: 7-21. 17.
Elazar M, Glenn JS. Combination of novel therapies for HDV. Viruses 2022; 14: 268. 18.
Caviglia GP, Ciancio A, Rizzetto M. A review of HDV infection. Viruses 2022; 14: 1749. 19.
Koh C, Heller T, Glenn JS. Pathogenesis of and new therapies for hepatitis D. Gastroenterology 2019; 156: 461-476.e1.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
|
|
